[1] Johnson S C,McClelland S E. Watching cancer cells evolve through chromosomal instability. Nature,2019,570:166-167.
[2] Tijhuis A E,Johnson S C,McClelland S E. The emerging links between chromosomal instability (CIN), metastasis, inflammation and tumour immunity. Mol Cytogenet,2019,12:17.
[3] Zhang W,Mao J H,Zhu W,et al. Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy. Nat Commun,2016,7:12619.
[4] Friedman S,Freitag M. Evolving Centromeres and Kinetochores. Adv Genet,2017,98:1-41.
[5] Freitag M. The kinetochore interaction network (KIN) of ascomycetes. Mycologia,2016,108:485-505.
[6] Tanaka K,Hirota T. Chromosomal instability: a common feature and a therapeutic target of cancer. Biochim Biophys Acta,2016,1866:64-75.
[7] Li Y M,Liu X H,Cao X Z,et al. Expression of centromere protein A in hepatocellular carcinoma. Zhonghua Bing Li Xue Za Zhi,2007,36(3):175-178.
[8] Li Y,Zhu Z,Zhang S,et al. ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth. PLoS One,2011,6:e17794.
[9] Liu L,Li Y,Zhang S,et al. Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells. Oncol Rep,2012,27:168-73.
[10] Li Y M,Zhu Z,Chen Y,et al. Effect of siRNA targeting centromere protein-A gene on biological behavior of HepG2 cells. Zhonghua Bing Li Xue Za Zhi,2008,37:124-128.
[11] Liu B,Luo H,Wu G,Liu J,Pan J,Liu Z. Low expression of spindle checkpoint protein, Cenp-E, causes numerical chromosomal abnormalities in HepG-2 human hepatoma cells. Oncol Lett,2015,10:2699-2704.
[12] Liu Z,Ling K,Wu X,et al. Reduced expression of cenp-e in human hepatocellular carcinoma. J Exp Clin Cancer Res,2009,28:156.
[13] Tang J C,Wu K,Zheng X,et al. GSK923295 as a potential antihepatocellular carcinoma agent causing delay on liver regeneration after partial hepatectomy. Chin Med J (Engl),2019,132:311-318.
[14] Varis A,Salmela A L,Kallio M J. Cenp-F (mitosin) is more than a mitotic marker. Chromosoma,2006,115:288-295.
[15] Kim H E,Kim D G,Lee K J,et al. Frequent amplification of CENPF, GMNN and CDK13 genes in hepatocellular carcinomas. PLoS One,2012,7:e43223.
[16] Dai Y,Liu L,Zeng T,et al. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma. Biochem Biophys Res Commun,2013,436:711-718.
[17] 李潇瑾,徐安健,周东虎,等. 着丝粒蛋白F在肝癌中的表达和对肝癌细胞生物学行为的影响. 临床和实验医学杂志,2018,17:2017-2021.
[18] Hong Y,Long J,Li H,et al. An analysis of immunoreactive signatures in early stage hepatocellular carcinoma. EBioMedicine,2015,2:438-446.
[19] Li S,Li X,Xu A,et al. Screening and clinical evaluation of dominant peptides of centromere protein F antigen for early diagnosis of hepatocellular carcinoma. Mol Med Rep,2018,17:4720-4728.
[20] Chen H,Zhang Y,Li S,et al. Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma. Cancer Manag Res,2018,10:1947-1958.
[21] Fukagawa T,Mikami Y,Nishihashi A,et al. CENP-H, a constitutive centromere component, is required for centromere targeting of CENP-C in vertebrate cells. EMBO J,2001,20:4603-4617.
[22] Lu G,Shan T,He S,et al. Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival. Oncol Rep,2013,30:2238-2244.
[23] Lu G,Hou H,Lu X,et al. CENP-H regulates the cell growth of human hepatocellular carcinoma cells through the mitochondrial apoptotic pathway. Oncol Rep,2017,37:3484-3492.
[24] Wang H,Liu W,Liu L,et al. Overexpression of centromere protein K (CENP-K) gene in hepatocellular carcinoma promote cell proliferation by activating AKT/TP53 signal pathway. Oncotarget,2017,8:73994-74005.
[25] Wang J,Li H,Xia C,et al. Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1. Onco Targets Ther,2019,12:869-882.
[26] Ying H,Xu Z,Chen M,et al. Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins. Onco Targets Ther,2018,11:689-702.
[27] Yang X Y,Wu B,Ma S L,et al. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery. Technol Cancer Res Treat,2018,17:1533033818794190. |
